Home Rheumatology Plantar fasciitis

Plantar fasciitis

Australian clinical guidelines for the diagnosis and management of plantar fasciitis

Introduction and Overview

Plantar fasciitis is the most common cause of heel pain in adults, accounting for approximately 15% of all foot complaints presenting to primary care and affecting around 10% of the population at some point in their lifetime. It is characterised by inferior heel pain arising from degenerative changes at the origin of the plantar fascia at the medial calcaneal tuberosity. Despite its name, plantar fasciitis is predominantly a degenerative enthesopathy (plantar fasciopathy) rather than a primary inflammatory condition; the histological finding is collagen degeneration and angiofibroblastic hyperplasia rather than acute inflammation. The condition is common in both sedentary individuals (particularly overweight middle-aged adults) and active athletes (runners, dancers). The hallmark symptom is sharp inferior heel pain with the first steps in the morning or after rest, typically improving with activity. Over 80% of patients recover with conservative management within 12 months.

ℹ️
Australian Context: Plantar fasciitis is extremely common in Australian general practice. The vast majority of cases resolve with conservative management over 6–12 months. Key management priorities are load modification, calf and plantar fascia stretching, appropriate footwear, and weight management in overweight patients. Corticosteroid injection provides short-term relief but does not accelerate long-term recovery and carries a small risk of plantar fascia rupture. Extracorporeal shockwave therapy is an evidence-based second-line option available in Australia. Physiotherapy referral is appropriate for cases not responding to first-line measures. Imaging is not required for typical presentations.
FeaturePlantar FasciitisFat Pad Atrophy / Other
LocationMedial calcaneal tuberosity; plantar fascia originCentral heel pad; diffuse inferior heel
Characteristic painFirst-step pain; improves with walking; worse after restPain throughout activity; worse with impact; no first-step pattern
Age / risk40–60 years; overweight; pes planus or cavus; runnersElderly; long-term corticosteroid use; prior heel injections
ManagementStretching, orthotics, load modification; ESWT if refractoryCushioned footwear; offloading; address underlying cause

Pathophysiology

Plantar fasciitis results from cumulative microtears at the plantar fascia origin that exceed the tissue's capacity for repair, producing a degenerative enthesopathy (fasciopathy) rather than a classical inflammatory condition.

Degenerative Mechanisms

  • Collagen degeneration — repetitive tensile and compressive loading at the medial calcaneal tuberosity causes microtears within the plantar fascia; histological examination reveals angiofibroblastic hyperplasia, collagen degeneration and disorganisation, and neovascularisation without significant inflammatory infiltrate; the process is analogous to tendinosis rather than tendinitis
  • Windlass mechanism dysfunction — the plantar fascia is a key component of the windlass mechanism: dorsiflexion of the toes tightens the fascia, raises the longitudinal arch, and supinates the foot during push-off; altered foot biomechanics (pes planus, pes cavus, reduced ankle dorsiflexion) increase stress at the fascial origin; excessive pronation is a significant contributor
  • Risk factors — obesity and overweight (BMI >30) significantly increase plantar fascia load; prolonged standing; reduced ankle dorsiflexion range (tight Achilles-gastrocnemius-soleus complex); sudden increase in training load; hard surfaces; poor footwear support; both pes planus and pes cavus increase fascial stress; leg length discrepancy; prolonged walking or standing occupations

Clinical Presentation

Plantar fasciitis has a characteristic clinical presentation that allows confident diagnosis in the majority of cases without imaging. The diagnosis is primarily clinical.

History

  • First-step pain (post-static dyskinesia) — sharp, stabbing heel pain with the first few steps in the morning or after prolonged sitting or rest; this is the hallmark symptom; pain typically improves after 5–10 minutes of walking as the fascia warms up and elongates; may worsen again after prolonged activity
  • Location — inferior heel pain; typically at the medial aspect of the calcaneal tuberosity (plantar fascia origin); may radiate proximally along the plantar fascia; rarely involves the central heel pad
  • Aggravating factors — barefoot walking (particularly on hard floors); first steps in the morning; prolonged standing; stair climbing; running; walking in unsupportive footwear; end-of-day activity after prolonged standing
  • Duration and natural history — symptoms often present for weeks to months before presentation; gradual onset in most cases; acute presentation can occur with sudden overload; over 80% resolve within 12 months with conservative management; a minority develop chronic plantar fasciopathy

Examination Findings

  • Point tenderness — maximal tenderness on direct palpation of the medial calcaneal tuberosity (plantar fascia origin); this is the most sensitive physical finding; tenderness along the plantar fascia mid-substance may also be present; central heel pad tenderness suggests fat pad pathology rather than fasciitis
  • Windlass test — passive dorsiflexion of the great toe (which tightens the plantar fascia via the windlass mechanism) reproduces heel pain; sensitivity approximately 32%, specificity 100%; highly specific when positive
  • Ankle dorsiflexion — assess with knee extended (gastrocnemius) and knee flexed (soleus); reduced dorsiflexion (<10 degrees with knee extended) indicates tight gastrocnemius-soleus complex β€” a modifiable risk factor; the SilfverskiΓΆld test differentiates gastrocnemius from soleus tightness
  • Foot posture — assess for pes planus (flat foot), pes cavus (high arch), and hindfoot valgus; excessive pronation increases plantar fascia tensile load
⚠️
Do Not Miss: Calcaneal stress fracture β€” focal bony tenderness; positive calcaneal squeeze test (medial-lateral compression); hop test positive; MRI required; non-weight bearing. Tarsal tunnel syndrome β€” burning, tingling, or numbness in heel and sole; positive Tinel sign over tarsal tunnel; nerve conduction studies. Seronegative spondyloarthropathy (enthesitis) β€” bilateral heel pain; associated back pain, inflammatory arthritis, skin or eye involvement; HLA-B27; ESR/CRP elevated; early morning stiffness >1 hour. Fat pad atrophy β€” central diffuse heel pain; elderly; prior steroid injections; cushioning and offloading. Haglund deformity / insertional Achilles tendinopathy β€” posterior superior heel pain; different to plantar fasciitis.

Investigations

Plantar fasciitis is a clinical diagnosis. Investigations are not required for typical presentations. Imaging and blood tests are used to exclude differential diagnoses or guide management in atypical or refractory cases.

  • Essential
    X-ray heel (lateral view)
    Not required for typical clinical presentation. Indicated when: atypical features present, symptoms not improving at 6 weeks, bony injury suspected. Plantar heel spur visible in 50% of plantar fasciitis patients but is not diagnostic β€” also present in 15–25% of asymptomatic individuals; spur reflects the site of fascial traction rather than the pain generator. Useful to exclude calcaneal stress fracture (periosteal reaction), bone tumour, or other bony pathology. Item 57706.
  • Recommended
    Ultrasound plantar fascia
    Confirms diagnosis and guides injection or shockwave therapy. Findings: plantar fascia thickness >4 mm (normal <4 mm) at calcaneal origin; hypoechoic signal; loss of fibrillar pattern; periosteal reaction. Also assesses for partial tear and excludes plantar fibroma. Dynamic ultrasound useful to assess windlass mechanism. Guides needle placement for corticosteroid injection. Item 55054.
  • Specialised
    MRI foot
    Indicated for atypical presentations, suspected calcaneal stress fracture (bone marrow oedema on STIR sequences), tarsal tunnel syndrome, or surgical planning. Not required for routine plantar fasciitis. Demonstrates plantar fascia thickening, signal abnormality, and bone marrow oedema at insertion. Item 63560.
  • Specialised
    Inflammatory markers and HLA-B27
    Indicated when seronegative spondyloarthropathy is suspected: bilateral heel pain, young patient, associated back pain, morning stiffness >1 hour, inflammatory arthritis, skin or eye involvement. ESR, CRP, HLA-B27, and rheumatology referral if enthesitis-pattern disease suspected.

Risk Stratification

Plantar fasciitis is stratified by duration and treatment response to guide escalation of care.

ACUTE (<3 MONTHS)
First-Line Conservative Management
First-step pain; typical presentation; duration <3 months; no prior treatment; no red flags
Stretching program (plantar fascia and calf); supportive footwear advice; heel pad or prefabricated orthosis; activity modification; weight management if overweight; analgesia; most resolve within 6–12 months
SUBACUTE (3–6 MONTHS)
Second-Line Escalation
Symptoms persisting beyond 3 months despite first-line treatment; significant functional impairment; reduced quality of life; prior conservative measures insufficient
Physiotherapy referral (manual therapy, taping, targeted exercise); corticosteroid injection (ultrasound-guided) for short-term pain relief; consider extracorporeal shockwave therapy (ESWT); custom foot orthoses; night splint for persistent morning pain
CHRONIC (>6 MONTHS)
Specialist Referral
Symptoms persisting >6 months despite comprehensive conservative management; severe functional limitation; confirmed on imaging; multiple prior treatment failures
Podiatry or orthopaedic referral; ESWT if not already trialled; platelet-rich plasma (PRP) injection in select cases; surgical plantar fascia release as last resort (rarely required); address systemic contributors (obesity, inflammatory arthropathy)

Pharmacological Management

Analgesia provides symptomatic relief while the natural healing process occurs. Corticosteroid injection provides short-term pain relief but does not alter the underlying disease course. NSAIDs have limited evidence for plantar fasciitis given the degenerative rather than inflammatory nature of the condition.

💊
Paracetamol
Panadol® | First-line analgesia
Dose1 g up to four times daily (maximum 4 g/day); as needed for pain
PBS Status✓ PBS: General benefit
NotesFirst-line analgesic; safe for long-term use at appropriate dose; most useful in the acute flare phase.
💊
NSAIDs (short-term)
Ibuprofen, naproxen | Adjunct analgesia
DoseIbuprofen 400 mg three times daily with food; naproxen 250–500 mg twice daily; short course 7–14 days
PBS Status✓ PBS: General benefit
NotesLimited evidence for plantar fasciitis specifically given non-inflammatory pathology; may provide short-term symptomatic relief in acute-phase pain. Topical NSAIDs (diclofenac gel) can be used as an alternative to minimise systemic side effects. Avoid prolonged use.
💊
Corticosteroid injection (ultrasound-guided)
Methylprednisolone or triamcinolone | Second-line
DoseMethylprednisolone acetate 40 mg with 1 mL lignocaine 1%; or triamcinolone acetonide 20–40 mg; single injection; ultrasound guidance strongly preferred; maximum 2 injections total
PBS Statusℹ PBS: Not specifically listed; injected as office procedure; ultrasound guidance item 55054
NotesProvides short-term pain relief (4–8 weeks); does not improve long-term outcomes compared to placebo at 12 months. Risk of plantar fascia rupture (estimated 2%) and heel fat pad atrophy with repeated injections. Ultrasound guidance improves accuracy and reduces complication risk. Limit to maximum 2 injections; do not use as sole treatment without concurrent rehabilitation.

Directed Therapy

Conservative management is the cornerstone of plantar fasciitis treatment and is effective in over 80% of patients within 12 months. The most evidence-supported interventions are plantar fascia and calf stretching, load modification, and supportive footwear.

Stretching Programs

  • Plantar fascia stretch — cross-legged seated position; grasp the toes and dorsiflex them to feel a stretch along the plantar fascia; hold 30 seconds; repeat 3 times; perform first thing in the morning before weight-bearing and after periods of rest; this is the single most evidence-supported intervention for plantar fasciitis; shown to be more effective than Achilles stretching alone in RCTs
  • Calf stretching — gastrocnemius stretch (knee extended, foot dorsiflexed against wall); soleus stretch (knee flexed); hold 30 seconds each; 3 repetitions; twice daily; reduces plantar fascia loading by improving ankle dorsiflexion range; targets the primary modifiable biomechanical risk factor
  • Intrinsic foot muscle strengthening — towel scrunches, marble pick-up, short foot exercises; strengthens the intrinsic foot musculature supporting the plantar arch; adjunct to stretching

Footwear and Orthoses

  • Supportive footwear — advise patients to avoid barefoot walking on hard surfaces (particularly in the morning); shoes with cushioned heel and good arch support; replace worn footwear; avoid flat, unsupportive footwear (flip-flops, ballet flats); supportive slippers or orthotics to be worn immediately on rising in the morning
  • Heel pads and prefabricated orthotics — silicone or cushioned heel pads provide immediate symptom relief; prefabricated arch support orthotics (available over-the-counter) are effective and cost-efficient; custom orthotics appropriate for complex biomechanical contributors but not superior to prefabricated orthotics for most patients
  • Night splints — hold foot in neutral dorsiflexion during sleep; maintain plantar fascia and Achilles in a lengthened position overnight; evidence supports use for persistent first-step morning pain; compliance is a limitation; particularly useful for morning pain that is the predominant symptom

Extracorporeal Shockwave Therapy (ESWT)

  • ESWT delivers focused acoustic energy to the plantar fascia insertion, promoting tissue healing and reducing pain; strong evidence base for chronic plantar fasciitis (>3 months duration); Meta-analyses demonstrate superiority over placebo and corticosteroid injection at 12-week and 12-month follow-up; multiple sessions (typically 3–5) required; available in major Australian cities at podiatry, sports medicine, and physiotherapy clinics; not PBS-listed but ESWT is clinically recommended as second-line therapy before surgical options

Weight Management

  • Obesity is a major modifiable risk factor for plantar fasciitis; even modest weight reduction (5–10% body weight) significantly reduces plantar fascia load during daily activity; weight management advice and referral to dietitian or structured weight management program is an important component of management in overweight and obese patients

Non-Pharmacological Management

Non-pharmacological management is the foundation of plantar fasciitis care. Patient education about the natural history, self-management strategies, and realistic recovery timelines is critical.

Patient Education

  • Natural history — educate that plantar fasciitis is a degenerative condition that typically resolves over 12 months with consistent conservative management; the condition is not dangerous and does not lead to permanent damage with appropriate management; compliance with stretching is the most important determinant of recovery; patients should not expect immediate relief β€” consistent stretching over weeks to months is required
  • Activity modification — reduce high-impact activity (running, jumping) during acute flare; cross-train with low-impact activity (swimming, cycling); return to impact activity gradually; avoid sudden increases in training load; barefoot walking on hard floors should be avoided especially in the morning

Physiotherapy

  • Physiotherapy encompasses manual therapy (soft tissue massage of plantar fascia and calf), taping techniques (low-Dye taping for short-term load reduction), gait assessment and retraining, targeted exercise prescription, and biomechanical correction; referral is appropriate for patients not responding to first-line GP management at 6–8 weeks, for runners, or for patients with complex biomechanical contributors

Low-Dye Taping

  • Low-Dye taping supports the medial longitudinal arch and reduces pronation, decreasing plantar fascia tensile load; provides effective short-term pain relief; useful during acute flares while footwear and orthotics are being sourced; applied by physiotherapist or podiatrist; patient can be taught self-application for daily use

Monitoring Parameters

Monitoring focuses on symptom response to conservative management, identifying patients who require escalation, and ruling out alternative diagnoses in non-responders.

ParameterFrequencyAction
First-step pain (NRS 0–10) and functional limitationGP review at 6 weeks; then 3-monthlySignificant improvement expected by 6 weeks; if no improvement at 6–8 weeks β€” review stretching compliance, footwear, BMI; consider physiotherapy referral; if no improvement at 3 months β€” ultrasound and consider corticosteroid injection or ESWT
Red flag features (new symptoms suggesting alternative diagnosis)Every reviewBilateral heel pain with back pain/morning stiffness β€” inflammatory screen, HLA-B27, rheumatology referral; new focal bony tenderness or positive calcaneal squeeze β€” X-ray and MRI to exclude stress fracture; burning/tingling β€” nerve conduction studies for tarsal tunnel
Post-injection response (if corticosteroid injected)4–6 weeks post-injectionIf good response (pain >50% reduced) β€” continue rehabilitation; if poor response β€” reassess diagnosis; ultrasound to confirm fasciitis versus alternative pathology; consider ESWT

Indications for Specialist Referral

  • Podiatry — complex biomechanical assessment; custom orthotics; ESWT delivery; chronic refractory plantar fasciitis
  • Sports medicine / physiotherapy — runners and athletes; gait retraining; return-to-sport planning; manual therapy
  • Rheumatology — suspected seronegative spondyloarthropathy (bilateral heel pain, enthesitis pattern, associated inflammatory features)
  • Orthopaedic surgery — chronic plantar fasciitis >12 months not responding to comprehensive conservative management; surgical release rarely required (<5% of cases)

Special Populations

Special considerations apply to runners, obese patients, and patients with seronegative spondyloarthropathy presenting with plantar heel enthesitis.

Runners and Athletes

  • Plantar fasciitis in runners is typically associated with training load errors (sudden mileage increase), inadequate footwear, and biomechanical contributors (limited dorsiflexion, pes planus); complete cessation of running is not required but high-volume training should be reduced; pool running and cycling maintain fitness; gait retraining (cadence increase, reduced overstriding) can reduce plantar fascia loading; physiotherapy and sports medicine referral is appropriate for competitive runners; return to full training after pain resolves with gradual volume increase

Obese and Overweight Patients

  • Obesity is the strongest modifiable risk factor for plantar fasciitis and chronic heel pain; weight loss of 5–10% body weight significantly reduces plantar fascia load during daily activities; address obesity as a primary treatment target through dietary modification, physical activity (low-impact initially), and referral to a structured weight management program or dietitian; bariatric surgery referral for morbid obesity refractory to conservative weight management; heel cushioning and supportive footwear are particularly important in this group

Seronegative Spondyloarthropathy

  • Enthesitis (inflammation at tendon and ligament insertions) is a cardinal feature of seronegative spondyloarthropathies including ankylosing spondylitis, psoriatic arthritis, and reactive arthritis; plantar fascial enthesitis may be the presenting feature; bilateral heel pain, associated back pain, morning stiffness >1 hour, inflammatory eye or bowel disease, or skin psoriasis should prompt evaluation; HLA-B27, CRP, ESR, and rheumatology referral; management differs from mechanical plantar fasciitis and requires disease-modifying therapy

Aboriginal and Torres Strait Islander Health Considerations

Aboriginal and Torres Strait Islander Health

Plantar fasciitis in Aboriginal and Torres Strait Islander (ATSI) peoples occurs in the context of higher rates of obesity and type 2 diabetes, high rates of physically demanding occupations and community sport participation, and limited access to podiatry and physiotherapy services in remote and rural settings. Seronegative spondyloarthropathy (reactive arthritis following streptococcal or other infections) is more prevalent in ATSI communities and may present with heel enthesitis.

Access to Podiatry and Physiotherapy
Podiatry and physiotherapy are the key allied health disciplines for plantar fasciitis management but are significantly under-resourced in remote ATSI communities. Telehealth consultations can guide stretching programs and footwear advice. Aboriginal Health Workers can provide education on stretching exercises and footwear modifications. Home-based stretching programs with printed or video resources are practical in low-resource settings. When available, NDIS or Medicare-funded allied health (Team Care Arrangement, GP Management Plan) can support access to podiatry and physiotherapy for eligible patients.
Obesity and Metabolic Risk
ATSI peoples have significantly higher rates of obesity and overweight, which are major risk factors for plantar fasciitis. Addressing obesity as a primary treatment target requires culturally sensitive dietary counselling and physical activity promotion. Traditional foods and physical activity patterns should be incorporated into weight management discussions. Low-impact exercise options (swimming, walking in water) are appropriate during the acute pain phase. Community-based nutrition and physical activity programs tailored for ATSI communities are more effective than individual-only approaches.
Footwear Access and Occupational Factors
Access to appropriate supportive footwear can be a significant barrier in remote ATSI communities due to cost and availability. Barefoot walking on hard surfaces is more common in remote communities and significantly increases plantar fascia load. GP prescriptions for orthotics or referral to NDIS-funded podiatry for orthotic provision can address footwear barriers. Occupational factors (construction, mining, agriculture, community patrol roles) involve prolonged standing and walking on hard surfaces, increasing plantar fasciitis risk and recurrence.
Reactive Arthritis and Enthesitis
Reactive arthritis following streptococcal pharyngitis, rheumatic fever, or gastrointestinal infections (Salmonella, Shigella, Campylobacter) is more prevalent in ATSI communities. Reactive arthritis can present with heel enthesitis mimicking or co-existing with mechanical plantar fasciitis. Bilateral heel pain, associated joint swelling, oral ulcers, urethral discharge, or recent infection should prompt consideration of reactive arthritis and appropriate investigation (ESR, CRP, HLA-B27, swab cultures, rheumatology referral). Management of reactive arthritis differs substantially from mechanical plantar fasciitis.

Appropriate Use of Medicine and Stewardship

Stewardship in plantar fasciitis focuses on avoiding unnecessary imaging, limiting corticosteroid injections, supporting evidence-based non-pharmacological interventions, and recognising when imaging or specialist referral is genuinely indicated.

⚠️
Common Stewardship Issues:
  • Unnecessary imaging: X-ray and ultrasound are not required for typical plantar fasciitis presentations. A plantar heel spur on X-ray does not change management. Reserve imaging for atypical features, diagnostic uncertainty, or to guide injection therapy.
  • Excessive corticosteroid injections: Limit to a maximum of 2 injections per foot. Repeated injections increase the risk of plantar fascia rupture and fat pad atrophy. Corticosteroid injection should never be used as the sole treatment β€” concurrent rehabilitation is essential. Do not inject without ultrasound guidance if possible.
  • Missing inflammatory enthesitis: Bilateral plantar fasciitis, young patients, or associated inflammatory features warrant evaluation for seronegative spondyloarthropathy before attributing both heels to mechanical plantar fasciitis.

GP Role

  • Diagnose clinically — characteristic first-step pain, medial calcaneal tenderness, positive windlass test; no imaging required for typical presentation
  • Initiate evidence-based first-line care — plantar fascia and calf stretching protocol; supportive footwear and heel pads; activity modification; weight management; analgesia
  • Review and escalate appropriately — 6–8 week review; physiotherapy referral if not improving; corticosteroid injection for persistent pain beyond 3 months (maximum 2); ESWT referral for chronic cases
  • Screen for inflammatory causes — investigate bilateral heel pain or inflammatory features; HLA-B27 and rheumatology referral if enthesitis-pattern suspected

Follow-up and Prevention

Follow-up in plantar fasciitis is symptom-guided. Most patients improve with consistent conservative management over 6–12 months. Prevention of recurrence centres on ongoing stretching, appropriate footwear, weight management, and gradual training load progression.

Presentation
Clinical diagnosis; educate on natural history; prescribe plantar fascia and calf stretching protocol; supportive footwear and heel pad advice; activity modification; paracetamol/NSAIDs; weight management discussion if overweight.
6–8 Weeks
Review symptom response; assess stretching compliance; reinforce footwear and activity modification; if insufficient improvement β€” physiotherapy referral; consider ultrasound-guided corticosteroid injection for persistent pain.
3 Months
If not improving β€” consider corticosteroid injection (if not already done); refer for ESWT; reassess diagnosis; check for inflammatory features; podiatry referral for custom orthotics and advanced management.
6–12 Months
Reassess; ESWT if not already trialled; consideration of PRP injection in specialist setting; orthopaedic referral for surgical release in rare refractory cases; long-term: continued stretching, weight maintenance, appropriate footwear.

References and Guidelines

  • Riddle DL, Schappert SM — Volume of ambulatory care visits and patterns of care for patients diagnosed with plantar fasciitis; Foot Ankle Int 2004
  • Digiovanni BF et al. — Plantar fascia-specific stretching versus nonspecific stretching for chronic heel pain; J Bone Joint Surg Am 2006
  • Rompe JD et al. — Shock wave therapy for chronic plantar fasciitis; Am J Sports Med 2009
  • Landorf KB, Menz HB — Plantar heel pain and fasciitis; BMJ Clin Evid 2008
  • Hawke F, Burns J — Understanding the nature and mechanism of foot pain; J Foot Ankle Res 2009
  • Therapeutic Guidelines: Musculoskeletal — Plantar fasciitis and heel pain; available via eTG complete
  • Australian Rheumatology Association — Spondyloarthropathy and enthesitis management guidelines
  • RACGP — Red Book: Musculoskeletal conditions in primary care; 2022 edition